Psychotherapy with psilocybin tested against depression

A clinical trial is underway to test whether psilocybin-assisted psychotherapy can help front-line clinicians who have developed depression and anxiety amid the COVID-19 pandemic. Psilocybin is a psychedelic naturally found in some mushrooms.

"Nurses right now and doctors are leaving the field in droves. We're on our way to a public health crisis because providers are leaving," said Anthony Back, the trial's lead investigator and a professor of medicine at the University of Washington School of Medicine. "This kind of mental health treatment is really a new way of thinking."

Learn more about the trial in our news release.

Access downloadable video assets with Back discussing the issues that front-line clinicians face.

UW Medicine